Thomson Medical's (SGX:A50) booked an attributable loss to owners of the company during the fiscal second half of the year ended June 30 of SG$34.7 million, against an attributable profit of SG$12.1 million a year earlier, according to a Friday filing with the Singapore Exchange.
Shares of the company were down over 3% in Friday trading.
Loss per share came in at SG$0.00131 compared with earnings per share of SG$0.00046 in the comparable period.
Revenue was up 6.9% year over year to SG$195.6 million from SG$183.0 million, due to strong performances from a newly opened oncology center in Malaysia.